Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Rectal Neoplasms 7 Colorectal Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 4 Neoplasms 3 Breast Carcinoma In Situ 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Bites and Stings 2 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Stress, Psychological 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Seminoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Prostatic Neoplasms 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1 Muscle Invasive Bladder Cancer 1 Motor Activity 1

Interventions

Radiotherapy, Adjuvant 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × High-Risk Cancer × Neoadjuvant Therapy × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡